Martin B. Leon教授谈对CIT未来期许
我想强调一下教育和培训在提高医生临床技巧方面至关重要的角色，而CIT就是这样一个绝佳的额外培训机会。中国的医生应主动寻求机会参与临床研究，亲身体验中国介入心脏病学令人惊叹的发展。
Martin B. Leon教授
Martin B. Leon教授：
今年的CIT已非常成熟：最新揭晓临床研究质量高；病例复杂程度达国际水平；主席团堪称顶级；会节设计巧妙而联系紧密。我认为CIT会继续强大，为中国的医生带来绝佳学习体验。我期待着中国成为国际介入心脏病学领域的领头者。
CIT快速发展的因素有很多：介入心脏病学领域的发展带来更多手术指导；医生培训质量更高，诊疗经验更加丰富；医院基础建设更加完善；医生有意愿去开展前沿临床研究。
我想强调一下教育和培训在提高医生临床技巧方面至关重要的角色，而CIT就是这样一个绝佳的额外培训机会。中国的医生应主动寻求机会参与临床研究，亲身体验中国介入心脏病学令人惊叹的发展。
This year’s CIT has been very mature, the late breaking trials are of higher quality, the cases are no less complex than those done anywhere else in the world, the faculty is superb, and the sessions are well developed with excellent interaction. I think CIT continues to grow, to provide good educational experiences for Chinese physicians. I expect China to establish itself among the leaders in the interventional cardiology field.
A number of factors have contributed to the rapid growth of CIT. The expansion of interventional cardiology provides very good tutorials on surgery. Now the physicians are better trained and more experienced, with better infrastructure in hospitals. They have the willingness to do clinical research of cutting edge topics.
I would like to emphasize the fundamental role of education in developing physicians’ clinical skills and CIT is just a good opportunity for additional training. Physicians in China should seek opportunities to participate in clinical research and be involved in the amazing evolution of interventional cardiology in China.
相关文章
评论
我要跟帖
